You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
Tyra Biosciences Raises Funds through Underwriting Agreement
PUBLIC · TYRASep 14, 2026•3 days ago
Amount Raised
$200 Million
Round Type
Funding Round
CarlsbadBiotechnologyHealth CareTherapeutics
Investors
Barclays Capital Inc.Cantor Fitzgerald & Co.Guggenheim Securities, LlcJefferies Llc
Description
On September 14, 2026, Tyra Biosciences, Inc. entered into an underwriting agreement for the issuance and sale of common stock and pre-funded warrants. The company intends to raise a total of $200 million in this funding round. This agreement involves the sale of over 9 million shares at an offering price of $22.03 per share
Company Information
Company
Tyra Biosciences
Location
Carlsbad, California, United States
About
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions.
Don't miss Tyra Biosciences's next move
Get an email the moment Tyra Biosciences raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Predictive Intelligence
Strategic
ML-powered predictions for Tyra Biosciences's next move
CarlsbadBiotechnologyHealth CareTherapeutics